In an important development demonstrating confidence in the global healthcare sector of India, Abu Dhabi Investment Authority (ADIA) has completed a definitive investment agreement for USD 200 million in Meril, a high-quality medical device company..
In a significant step to enhance its natural health portfolio, SuanNutra Group's European distribution division Gonmisol has signed an exclusive distribution agreement with Indian-based K Patel Phyto Extractions...
Roche faced a regulatory setback today as the U.S. FDA issued a Complete Response Letter (CRL) for its bid to expand Columvi (glofitamab) in combination with gemcitabine and oxaliplatin (GemOx) for certain DLBCL patients...
Sun Pharma announced that its monoclonal antibody drug ILUMYA (tildrakizumab 100 mg) has demonstrated favorable results in two Phase 3 clinical trials in active psoriatic arthritis
Top-line findings from two Phase 3 clinical trials assessing the safety and effectiveness of tildrakizumab 100 mg (ILUMYA) given over a 24-week period for the treatment of active psoriatic arthritis were released today by Sun Pharmaceutical
.png)
India is going to change the microbial contamination limits as per Schedule M in the Drugs and Cosmetics Rules to the global WHO limits in a major initiative to improve pharmaceutical manufacturing standards. The decision was taken at the Drugs...
In a breakthrough for health care, Kozhikode has become the first district in Kerala to provide continuous glucose monitoring (CGM) systems free of charge to children diagnosed with Type 1 Diabetes (T1D)...
Indian Council of Medical Research (ICMR), along with Regional Medical Research Centre, Bhubaneswar (RMRCBB) and National Institute of Malaria Research (NIMR) is leading the formulation of a new indigenous malaria vaccine called AdFalciVax.
.jpeg)
The critical momentum to the biomanufacturing sector in India is being spurred by the fact that Danaher India, a subsidiary of world science and technology giant Danaher Corporation, has entered into a strategic alliance with the Translational Health
In an interaction with India Pharma Outlook, Dr. Mohan Keshavamurthy, Principal Director – Renal Sciences at Fortis Healthcare, discusses how robotic surgery is revolutionizing kidney transplants in India by improving surgical precision, reducing war
, CDSCO.jpg)